Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Thermal sintering of ePTFE requires heating assemblies between 340°C and 360°C to encapsulate the stent. Exposing a pre-shaped nitinol frame to these elevated process temperatures during covering risks altering the shape setting and mechanical training of the underlying alloy.

Related Insights

Engineering teams meticulously document component details but often fail to apply the same rigor to assembly specifications. This oversight becomes a major source of failure, especially when transitioning from pilot lines to high-volume manufacturing.

In standard ePTFE sintering, two polymer layers fuse only to each other through the stent's openings rather than adhering to the metal struts. Because this creates only a mechanical capture instead of a direct chemical bond, voids can develop near the struts during loading and deployment.

Replacing manual suturing with polymer lamination requires fabrics with sufficient elongation, such as knitted textiles, so the material stretches alongside the collapsing metal frame. When using inelastic woven fabrics, the stent frame must be sewn loosely so it can slide through sutures during crimping.

Engineers often finalize a bare metal scaffold before addressing its covering, expecting the membrane to not affect radial strength or crimp profile. However, a covered stent behaves as a composite material where the scaffold, polymer, and vessel properties interact and must be designed simultaneously.

When screw lengths differ by only a few millimeters, assemblers can easily use the wrong one. This may seem to fit correctly but results in insufficient thread engagement, compromising the product's structural integrity, especially under stress like thermal cycling.

Engineering teams often default to hand-sewn stent covers in early phases because manual suturing is readily accessible and can be performed in-house. This initial convenience biases downstream architecture, committing programs to design constraints based on early prototyping ease rather than clinical optimization.

Because chronic animal studies are costly and slow, engineering teams frequently receive in vivo data very late in product development. Consequently, issues like unexpected thrombosis or density mismatches are uncovered just prior to clinical trials, forcing abrupt redesigns between product generations.

Working in an injection molding factory teaches a student engineer that perfect CAD designs are meaningless without understanding manufacturing realities like process variables (heat, cooling time) and tolerances that can ruin a part.

The primary challenge for many MedTech innovations is not the initial science but translating a lab process into a robust, scalable, and GMP-compliant manufacturing system. This requires a shift from proving a concept to ensuring consistent quality and patient safety.

For precise and repeatable catheter development, engineers can create cheap, effective tooling in-house. A simple example is 3D printing a small fixture with a built-in razor blade slot, which guarantees a perfectly straight cut on an extrusion every time, preventing downstream issues.